Protagonist raises $18m series B
Menlo Park, California-based Protagonist Therapeutics has raised a total of $18m in a series B financing round, having just received $4m from new investor Pharmastandard International.
Menlo Park, California-based Protagonist Therapeutics has raised a total of $18m in a series B financing round, having just received $4m from new investor Pharmastandard International.